Enzyme Therapeutic for Ischemia and Reperfusion Injury in Organ Transplantation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34617335.
- Also identified by DOI 10.1002/adma.202105670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ischemia-reperfusion injury (IRI) remains as a critical challenge for organ transplantation. Herein, an enzyme therapeutic based on superoxide dismutase and catalase for effective mitigation of IRI and pathogen-induced liver injury is reported, providing a therapeutic for organ transplantation and other diseases.
Medical subject headings
- Organ Transplantation
- Reperfusion Injury